百利天恒股价跌5.15%，建信基金旗下1只基金重仓，持有7.27万股浮亏损失127.27万元

Group 1 - The core viewpoint of the news is that Baili Tianheng's stock price has dropped by 5.15%, currently trading at 322.50 CNY per share, with a total market capitalization of 129.32 billion CNY [1] - Baili Tianheng Pharmaceutical Co., Ltd. is located in Chengdu, Sichuan Province, and was established on August 17, 2006, with its listing date on January 6, 2023 [1] - The company's main business involves the research, production, and sales of pharmaceuticals, with revenue recognition primarily occurring at a specific point in time (99.57%) and over a specific period (0.43%) [1] Group 2 - From the perspective of fund holdings, one fund under Jianxin Fund has a significant position in Baili Tianheng, with the Jianxin SSE STAR Market Comprehensive ETF (589880) holding 72,700 shares, accounting for 1.73% of the fund's net value [2] - The Jianxin SSE STAR Market Comprehensive ETF (589880) was established on February 20, 2025, with a latest scale of 1.248 billion CNY and a cumulative return of 24.63% since inception [2] - The fund manager, Ge Luyu, has been in charge for 2 years and 246 days, with the total asset size of the fund being 1.477 billion CNY, achieving a best return of 29.69% and a worst return of 19.11% during his tenure [2]